Health Catalyst (HCAT) Misses Q3 EPS by 38c

Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of ($0.39), $0.38 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $73.8 million versus the consensus estimate of $72.67 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Health Catalyst Inc. (HCAT) PT Lowered to $1.50 at Wells Fargo